Ferrous Gluconate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB14488 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 31 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Plummer-Vinson syndrome | KG + DL |
| 2 | vitamin B12- and folate-independent constitutional megaloblastic anemia | KG + DL |
| 3 | non-syndromic esophageal malformation | KG + DL |
| 4 | biotin metabolic disease | KG + DL |
| 5 | vitamin deficiency disorder | KG + DL |
| 6 | esophageal disease | KG + DL |
| 7 | injury | KG + DL |
| 8 | segmental odontomaxillary dysplasia | KG + DL |
| 9 | florid cemento-osseous dysplasia | KG + DL |
| 10 | perinatal disease | KG + DL |
| 11 | radiation or chemically induced disorder | KG + DL |
| 12 | disease by subcellular system affected | KG + DL |
| 13 | iatrogenic disease | KG + DL |
| 14 | cell proliferation disorder | KG + DL |
| 15 | regional odontodysplasia | KG + DL |
| 16 | IRIDA syndrome | KG + DL |
| 17 | Keshan disease | KG + DL |
| 18 | folic acid deficiency anemia | KG + DL |
| 19 | steatitis | KG + DL |
| 20 | ariboflavinosis | KG + DL |
| 21 | swayback | KG + DL |
| 22 | potassium deficiency | KG + DL |
| 23 | choline deficiency disease | KG + DL |
| 24 | esophageal ulcer | KG + DL |
| 25 | vitamin A deficiency (disease) | KG + DL |
| 26 | protein-energy malnutrition | KG + DL |
| 27 | magnesium deficiency | KG + DL |
| 28 | inborn error of biotin metabolism | KG + DL |
| 29 | esotropia | KG + DL |
| 30 | TFRC-related combined immunodeficiency | KG + DL |
| 31 | severe nonproliferative diabetic retinopathy | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.